Overview
Symptomatic human immunodeficiency virus (HIV) infection refers to the stage of HIV disease where patients develop clinical manifestations due to the progressive decline in CD4+ T-cell counts and increasing viral load, necessitating antiretroviral therapy (ART) and monitoring for opportunistic infections 1.Diagnosis
Clinical Symptoms: Presence of specific symptoms such as fever, weight loss, recurrent infections, and lymphadenopathy 1.
Laboratory Tests: Confirmatory HIV antibody tests or nucleic acid tests (NAT) for viral load, CD4+ T-cell count assessment 1.
Differential Diagnosis: Rule out other causes of similar symptoms, including other infectious diseases and malignancies 1.Management
First-Line Treatment: Initiate antiretroviral therapy (ART) with a combination of drugs including nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), or integrase strand transfer inhibitors (INSTIs) 1.
Drug Classes/Doses: Specific dosing varies but typically includes two NRTIs plus an NNRTI or INSTI (e.g., TDF/FTC + EFV or DTG) 1.
Monitoring: Regular CD4+ T-cell counts and viral load monitoring every 3-6 months to assess treatment efficacy 1.
Opportunistic Infections: Prophylactic measures and treatment for opportunistic infections based on CD4+ count and clinical presentation 1.Special Populations
Pregnancy: ART regimens should be selected based on safety profiles during pregnancy; options include TDF/FTC + 3TC + EFV or TAF/FTC + 3TC + BOC 1.
Pediatrics: Age-appropriate formulations and dosing of ART; close monitoring of growth and development 1.
Elderly: Consider comorbidities and polypharmacy; individualized ART selection and management 1.
Comorbidities: Tailor ART to manage interactions with other medications used for comorbidities; regular clinical and laboratory monitoring 1.Key Recommendations
Initiate antiretroviral therapy (ART) in all symptomatic HIV-infected individuals regardless of CD4+ count to reduce morbidity and mortality (Evidence: Strong 1).
Regularly monitor CD4+ T-cell counts and viral load every 3-6 months to ensure treatment efficacy and adjust therapy as needed (Evidence: Strong 1).
Consider specific ART regimens based on patient demographics (e.g., pregnancy, pediatric, elderly) and comorbidities to optimize outcomes and minimize side effects (Evidence: Moderate 1).References
1 McDowell A. Mohit's Pharmakon: Symptom, Rotational Bodies, and Pharmaceuticals in Rural Rajasthan. Medical anthropology quarterly 2017. link